Skip to main content

Table 1 Absorbed dose per unit of orally administered 99mTc-pertechnetate and 131I-iodide activity calculated with IDAC-Dose2.1 or DCAL

From: IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms

Organ

IDAC-Dose2.1

DCAL

99mTc-pertechnetate

131I-iodide

Adult male

Adult female

Adult male

Adult female

Adult male

Adult female

Adrenals

8.7E−03

1.0E−02

9.0E−02

1.0E−01

9.0E−02

1.0E−01

Brain

1.6E−03

1.9E−03

5.9E−02

8.9E−02

5.9E−02

8.9E−02

Breast

2.8E−03

2.4E−03

6.4E−02

1.4E−01

6.4E−02

1.4E−01

Colon wall

3.2E−02

3.5E−02

6.7E−02

6.4E−02

6.7E−02

6.4E−02

Endosteum (bone surface)

5.1E−03

6.8E−03

1.0E−01

1.3E−01

1.0E−01

1.3E−01

ET region

1.7E−03

2.3E−03

5.5E−01

8.2E−01

5.5E−01

8.2E−01

Eye lenses

1.0E−03

1.3E−03

6.0E−02

9.6E−02

6.0E−02

9.6E−02

Gallbladder wall

1.2E−02

8.4E−03

7.5E−02

8.9E−02

7.5E−02

8.9E−02

Heart wall

8.2E−03

7.4E−03

2.4E−01

2.5E−01

2.4E−01

2.5E−01

Kidneys

1.1E−02

1.3E−02

2.0E−01

2.3E−01

2.0E−01

2.3E−01

Liver

8.4E−03

7.8E−03

1.4E−01

1.6E−01

1.4E−01

1.6E−01

Lungs

4.7E−03

4.9E−03

2.9E−01

3.3E−01

2.9E−01

3.3E−01

Lymphatic nodes

6.7E−03

7.5E−03

9.1E−01

9.7E−01

9.1E−01

9.7E−01

Muscle

2.6E−03

3.4E−03

8.9E−02

1.3E−01

8.9E−02

1.3E−01

Oesophagus

6.6E−03

6.6E−03

2.2E+00

2.5E+00

2.2E+00

2.5E+00

Oral mucosa

2.1E−03

2.7E−03

2.2E−01

5.0E−01

2.2E−01

5.0E−01

Ovaries

7.4E−03

5.9E−02

5.9E−02

Pancreas

1.6E−02

1.5E−02

8.7E−02

9.8E−02

8.7E−02

9.8E−02

Prostate

3.8E−03

5.4E−02

5.4E−02

Red (active) bone marrow

5.2E−03

7.4E−03

2.0E−01

2.4E−01

2.0E−01

2.4E−01

Salivary glands

7.3E−03

9.2E−03

4.4E−01

6.9E−01

4.4E−01

6.9E−01

Skin

1.7E−03

2.1E−03

5.7E−02

7.2E−02

5.7E−02

7.2E−02

Small intestine wall

1.1E−02

1.4E−02

5.6E−02

6.9E−02

5.6E−02

6.9E−02

Spleen

9.2E−03

1.3E−02

1.0E−01

1.2E−01

1.0E−01

1.2E−01

Stomach wall

3.1E−02

3.1E−02

5.8E−01

5.9E−01

5.8E−01

5.9E−01

Testes

1.9E−03

2.1E−02

2.1E−02

Thymus

3.0E−03

3.1E−03

2.4E+00

2.1E+00

2.4E+00

2.1E+00

Thyroid

4.2E−02

5.1E−02

3.6E+02

4.4E+02

3.6E+02

4.4E+02

Urinary bladder wall

6.0E−03

8.0E−03

1.2E−01

1.3E−01

1.2E−01

1.3E−01

Uterus/cervix

7.3E−03

6.8E−02

6.8E−02

Effective dose (publ. 60) [mSv/MBq]

1.3E−02

1.5E−02

1.9E+01

2.2E+01

  

Effective dose (publ. 103) [mSv/MBq]

1.4E−02

 

1.6E+01

 

1.6E+01

 
  1. Data are given in mGy/MBq unless otherwise noted. Effective dose was calculated using the two sets of tissue weighting factors given in ICRP Publications 60 and 103